Medtech CDMO: Market and M&A Global Trends in 2024
Despite a strenuous past year in the medtech industry, the global medtech contract development and manufacturing (CDMO) market has continued to grow steadily, reaching $81.5B in 2023. Over half of worldwide industry revenues can be attributed to the resilient performance of more than 600 CDMOs across European and US markets.
This webinar investigates the current state of the global medtech CDMO industry and highlight Europe as a promising frontier for consolidation. Attendees will get key insights surrounding this dynamic market, including:
- The market trends that impact the performance of global medtech CDMOs today
- An assessment of Western Europe’s CDMO landscape that identifies the region’s core capabilities and end markets
- A 2024 outlook for medtech CDMOs that contextualizes mergers and acquisitions (M&A) activity from 2023 with expected market opportunities and risks
This webinar marks the release of Alira Health’s annual 2024 Global Medtech Contract Manufacturing Report.
The webinar is hosted by MassMEDIC, the largest regional medtech association in the United States, with over 300 members representing manufacturers, product developers, suppliers, research institutions and academic health centers.